These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 35269889)
1. Regulation by Different Types of Chaperones of Amyloid Transformation of Proteins Involved in the Development of Neurodegenerative Diseases. Muronetz VI; Kudryavtseva SS; Leisi EV; Kurochkina LP; Barinova KV; Schmalhausen EV Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269889 [TBL] [Abstract][Full Text] [Related]
2. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies. Ebrahimi-Fakhari D; Saidi LJ; Wahlster L Acta Neuropathol Commun; 2013 Dec; 1(1):79. PubMed ID: 24314025 [TBL] [Abstract][Full Text] [Related]
3. Chaperonins induce an amyloid-like transformation of ovine prion protein: the fundamental difference in action between eukaryotic TRiC and bacterial GroEL. Kiselev GG; Naletova IN; Sheval EV; Stroylova YY; Schmalhausen EV; Haertlé T; Muronetz VI Biochim Biophys Acta; 2011 Dec; 1814(12):1730-8. PubMed ID: 21856455 [TBL] [Abstract][Full Text] [Related]
4. Prions and chaperones: friends or foes? Stroylova YY; Kiselev GG; Schmalhausen EV; Muronetz VI Biochemistry (Mosc); 2014 Aug; 79(8):761-75. PubMed ID: 25365486 [TBL] [Abstract][Full Text] [Related]
5. The chaperonin TRiC is blocked by native and glycated prion protein. Kudryavtseva SS; Stroylova YY; Kurochkina LP; Muronetz VI Arch Biochem Biophys; 2020 Apr; 683():108319. PubMed ID: 32101762 [TBL] [Abstract][Full Text] [Related]
6. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis]. Yoshida K; Higuchi K; Ikeda S Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474 [TBL] [Abstract][Full Text] [Related]
7. Glyceraldehyde-3-phosphate dehydrogenase: Aggregation mechanisms and impact on amyloid neurodegenerative diseases. Muronetz VI; Barinova KV; Stroylova YY; Semenyuk PI; Schmalhausen EV Int J Biol Macromol; 2017 Jul; 100():55-66. PubMed ID: 27215901 [TBL] [Abstract][Full Text] [Related]
8. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation. Nerelius C; Fitzen M; Johansson J Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101 [TBL] [Abstract][Full Text] [Related]
9. Impact of Amyloid Polymorphism on Prion-Chaperone Interactions in Yeast. Killian AN; Miller SC; Hines JK Viruses; 2019 Apr; 11(4):. PubMed ID: 30995727 [TBL] [Abstract][Full Text] [Related]
14. Truncation-Driven Lateral Association of α-Synuclein Hinders Amyloid Clearance by the Hsp70-Based Disaggregase. Franco A; Cuéllar J; Fernández-Higuero JÁ; de la Arada I; Orozco N; Valpuesta JM; Prado A; Muga A Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884786 [TBL] [Abstract][Full Text] [Related]
15. Natural and Synthetic Derivatives of Hydroxycinnamic Acid Modulating the Pathological Transformation of Amyloidogenic Proteins. Muronetz VI; Barinova K; Kudryavtseva S; Medvedeva M; Melnikova A; Sevostyanova I; Semenyuk P; Stroylova Y; Sova M Molecules; 2020 Oct; 25(20):. PubMed ID: 33053854 [TBL] [Abstract][Full Text] [Related]
16. Preventing α-synuclein aggregation: the role of the small heat-shock molecular chaperone proteins. Cox D; Carver JA; Ecroyd H Biochim Biophys Acta; 2014 Sep; 1842(9):1830-43. PubMed ID: 24973551 [TBL] [Abstract][Full Text] [Related]
17. Chaperone-dependent amyloid assembly protects cells from prion toxicity. Douglas PM; Treusch S; Ren HY; Halfmann R; Duennwald ML; Lindquist S; Cyr DM Proc Natl Acad Sci U S A; 2008 May; 105(20):7206-11. PubMed ID: 18480252 [TBL] [Abstract][Full Text] [Related]
18. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases? Ritchie DL; Barria MA Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845 [TBL] [Abstract][Full Text] [Related]